GRACE EKE: Open Payments
NPI 1629561345 · FAYETTEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$825 in 36 payments from 10 companies in 2025. Trend: 2023 $1,013 · 2024 $1,317 · 2025 $825
Food & beverage: $823Education: $2
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $196 |
| Amgen Inc. | 5 | $129 |
| Ardelyx, Inc. | 5 | $124 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $119 |
| Novo Nordisk Inc | 5 | $94 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $92 |
| AKEBIA THERAPEUTICS INC | 1 | $30 |
| Lilly USA, LLC | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $14 |
| Travere Therapeutics, Inc. | 1 | $2 |
Products named: FARXIGA, JARDIANCE, KRYSTEXXA, IBSRELA, Kerendia, Ozempic, Vafseo, Wegovy.
Industry payments across GA — which companies pay providers there.
